Pharma Tips

US Firm Slaps Patent Suit on Dr Reddy’s

By: Pharma News | Views: 1044 | Date: 29-Jun-2013

US-based AbbVie Inc has slapped patent infringement suit against Dr Reddy’s Laboratories Limited alleging that the city-based drug maker had infringed on three patents of its drug Zemplar on six counts. AbbVie along with Wisconsin Alumni Research Foundation filed a petition in this regard at the US District Court for the District of Delaware on June 6. Zemplar (Paricalcitol) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associat

US firm slaps patent suit on Dr Reddy’s

Dr. Reddy's Labs Research Center

US-based AbbVie Inc has slapped patent infringement suit against Dr Reddy’s Laboratories Limited alleging that the city-based drug maker had infringed on three patents of its drug Zemplar on six counts. AbbVie along with Wisconsin Alumni Research Foundation filed a petition in this regard at the US District Court for the District of Delaware on June 6. Zemplar (Paricalcitol) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.

“DRL committed an act of infringement by filing an Abbreviated New Drug Application with a Paragraph IV Certification that seeks FDA-marketing approval for DRL generic versions of AbbVie’s paricalcitol injection products prior to expiration of the patents-in-suit,” the company said in the petition.

 

The Chicago-based pharma firm has requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL’s generic paricalcitol injectable products before the expiration of said patents. Dr Reddy’s filed an ANDA with the US Food and Drug Administration, seeking approval to sell a generic copy of Zemplar injectable products in 2 microgram/ml and 5 microgram/ml formulations, prior to the expiration of the patents owned by and exclusively licensed to the complainants, the petition said.

 

AbbVie, in its annual report 2012, said it generated $383 million from Zemplar sales including $230 from the US. Two patents (799 and 758) will expire on April 8, 2018.Wisconsin Alumni research foundation holds the rights for patent no. 815, which will expire on July 13, 2015.

 

“DRL has committed and will commit acts of infringement of the patents-in-suit that create a justiciable case or controversy between plaintiffs and DRL,” the petitioners alleged.


Previous Page Next Page

People Searching On This Page:
  • Dr Reddys
  • dr. reddy
  • dr reddy's laboratories inc CONTROVERSIES
  • article on flow through cell disolution apparatus patent
  • dr reddys patent infringement cases
  • Dr Reddy's Laboratories Fines OR OR OR Controversy OR OR OR Litigation OR OR OR illegal OR OR OR crime OR OR OR conviction OR OR OR guilt OR OR OR arrest OR OR OR mob OR OR OR mafia OR OR OR allegation OR OR OR launder OR OR OR corruption OR OR OR acc

Related Pages


Use & Abuse of Pain Killers : Focus on Methadone

Use & Abuse of Pain Killers : Focus on Methadone

Articles | Clinical Research | Clinical Case Study
Date:
27-Jul-2013  Views: 1304

Prescription painkiller overdoses were responsible for more than 15,500 deaths in 2009. While all prescription painkillers have contributed to an incr ...
Drug Dissolution Apparatus IV USP  (Flow-through-Cell)

Drug Dissolution Apparatus IV USP (Flow-through-Cell)

Articles | Pharmaceutics | Tablet
Date:
28-Mar-2011  Views: 15479

The flow-through-cell apparatus (Apparatus I is consists of a reservoir for the dis¬solution medium and a pump that force dissolution medium through t ...
Drug Dissolution Apparatus III USP (Reciprocating Cylinder)

Drug Dissolution Apparatus III USP (Reciprocating Cylinder)

Articles | Pharmaceutics | Tablet
Date:
28-Mar-2011  Views: 21818

The reciprocating cylinder was proposed by Beckett and coworkers41. and its incorporation into the USP followed in1991. The idea to generate a new tes ...
Drug Dissolution Apparatus II USP (Paddle)

Drug Dissolution Apparatus II USP (Paddle)

Articles | Pharmaceutics | Tablet
Date:
24-Mar-2011  Views: 24833

The paddle apparatus (Apparatus II) consists of a special, coated paddle that minimizes turbulence due to stirring. The paddle is attached vertically ...
Drug Dissolution  Apparatus-I  USP (Rotating Basket)

Drug Dissolution Apparatus-I USP (Rotating Basket)

Articles | Pharmaceutics | Tablet
Date:
24-Mar-2011  Views: 23167

The rotating basket apparatus (Apparatus 1) consists of a cylindrical basket held by a motor shaft. The basket holds the sample and rotates in a round ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

16  + 3 =     
Comments
People Searched About:
Dr Reddys   |   Dr. Reddy   |   Dr Reddy'S Laboratories Inc CONTROVERSIES   |   Article On Flow Through Cell Disolution Apparatus Patent   |   Dr Reddys Patent Infringement Cases   |   Dr Reddy'S Laboratories Fines OR OR OR Controversy OR OR OR Litigation OR OR OR Illegal OR OR OR Crime OR OR OR Conviction OR OR OR Guilt OR OR OR Arrest OR OR OR Mob OR OR OR Mafia OR OR OR Allegation OR OR OR Launder OR OR OR Corruption OR OR OR Acc   |  
Google : 193 times | Yahoo : 15 times | Bing : 17 times |